Basics Viatris Inc. IPO Date: November 13, 2020 Sector: Healthcare Industry: Pharma Market Cap: $10.09B Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 1.31% Avg Daily Range (30 D): $0.12 | 1.47% Avg Daily Range (90 D): $0.14 | 1.56% Institutional Daily Volume Avg Daily Volume: 8.34M Avg Daily Volume (30 D): 10.99M Avg Daily Volume (90 D): 10.91M Trade Size Avg Trade Size (Sh.): 192 Avg Trade Size (Sh.) (30 D): 214 Avg Trade Size (Sh.) (90 D): 208 Institutional Trades Total Inst.Trades: 7,918 Avg Inst. Trade: $4.5M Avg Inst. Trade (30 D): $6.15M Avg Inst. Trade (90 D): $6.11M Avg Inst. Trade Volume: .38M Avg Inst. Trades (Per Day): 6 Market Closing Trades Avg Closing Trade: $16.99M Avg Closing Trade (30 D): $30.14M Avg Closing Trade (90 D): $27.26M Avg Closing Volume: 1.48M         News Jun 2, 2025 @ 12:00 PM Opus Genetics Announces LYNX-2 Phase 3 Trial Met i... Source: N/A May 31, 2025 @ 11:07 AM VTRS CLASS NOTICE: Viatris Inc. Investors may have... Source: N/A May 29, 2025 @ 11:22 PM VTRS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIR... Source: N/A May 29, 2025 @ 2:22 AM VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INV... Source: Claimsfiler May 28, 2025 @ 1:52 AM VIATRIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTO... Source: Kahn Swick & Foti, Llc Financials   TTM Q1 2025 Q3 2024 Basic EPS $-2.55 $.08 Diluted EPS $-2.55 $.08 Revenue $ $ 3.25B $ 3.75B Gross Profit $ $ 1.16B $ 1.46B Net Income / Loss $ $ -3042M $ 94.8M Operating Income / Loss $ $ -2882.2M $ 225.9M Cost of Revenue $ $ 2.09B $ 2.29B Net Cash Flow $ $ 20.2M $ 961.6M PE Ratio     Splits Oct 09, 2003:   3:2 Jan 28, 2003:   3:2